GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Amicogen Inc (XKRX:092040) » Definitions » Purchase Of Investment

Amicogen (XKRX:092040) Purchase Of Investment : ₩-14,674 Mil (TTM As of Mar. 2025)


View and export this data going back to 2013. Start your Free Trial

What is Amicogen Purchase Of Investment?

Amicogen's purchase of investment for the three months ended in Mar. 2025 was ₩-405 Mil. It means Amicogen spent ₩405 Mil on purchasing investments. Amicogen's purchase of investment for the trailing twelve months (TTM) ended in Mar. 2025 was ₩-14,674 Mil.

Compared with last quarter (₩-3,055 Mil in Dec. 2024 ), Amicogen spent less money on purchasing investments in Mar. 2025 (₩-405 Mil).

Amicogen Purchase Of Investment Historical Data

The historical data trend for Amicogen's Purchase Of Investment can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Amicogen Purchase Of Investment Chart

Amicogen Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Purchase Of Investment
Get a 7-Day Free Trial Premium Member Only Premium Member Only -16,443.28 -154,181.73 -101,208.85 -54,512.64 -22,602.90

Amicogen Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Purchase Of Investment Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -8,333.31 -2,776.71 -8,438.33 -3,054.56 -404.85

Amicogen Purchase Of Investment Calculation

Purchase of Investments represents cash outflow on the purchase of investments in securities.

Purchase Of Investment for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was ₩-14,674 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Amicogen Purchase Of Investment Related Terms

Thank you for viewing the detailed overview of Amicogen's Purchase Of Investment provided by GuruFocus.com. Please click on the following links to see related term pages.

Amicogen Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Amicogen Inc (XKRX:092040) » Definitions » Purchase Of Investment
Comparable Companies
XKRX:293780 XKRX:293480 XKRX:000520 XKRX:008490 XKRX:016580 XKRX:000020 XKRX:234080 XKRX:102460 XKRX:271980 XKRX:023910 ZTS XTER:MRK NSE:SUNPHARMA TSE:4502 LSE:HLN XSWX:GALD XSWX:SDZ HKSE:03692 NSE:DIVISLAB XTAE:TEVA
Traded in Other Exchanges
N/A
Address
1259-64, Dongbu-ro, Gyeongsangnam-do, Jinseong-myeon, KOR, 660-852
Website
http://www.amicogen.com
Amicogen Inc is an industrial biotechnology company operating in Korea. It is engaged in the development, production, and distribution of enzymes, bio-new materials, and healthcare food. The company's product portfolio includes special enzymes, N-acetylglucosamine (NAG), pinitol, D-Chiro-inositol (DCI), collagen peptides (CP), and protein A chromatography resins.

Amicogen Headlines

No Headlines